Cellectar Biosciences Inc... (CLRB)
NASDAQ: CLRB
· Real-Time Price · USD
0.24
-0.00 (-0.29%)
At close: May 15, 2025, 10:21 AM
-0.29% (1D)
Bid | 0.24 |
Market Cap | 11.11M |
Revenue (ttm) | n/a |
Net Income (ttm) | -24.54M |
EPS (ttm) | -1.4 |
PE Ratio (ttm) | -0.17 |
Forward PE | -0.35 |
Analyst | Buy |
Ask | 0.24 |
Volume | 210,015 |
Avg. Volume (20D) | 985,832 |
Open | 0.24 |
Previous Close | 0.24 |
Day's Range | 0.23 - 0.24 |
52-Week Range | 0.22 - 3.45 |
Beta | 0.48 |
About CLRB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLRB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-13.54%
CLRB stock has given up its prior gain. Cellectar ...
Unlock content with
Pro Subscription
2 weeks ago
-13.54%
Cellectar Biosciences shares are trading higher after the company announced a plan to explore strategic alternatives.

2 days ago · seekingalpha.com
Cellectar Biosciences Inc. (CLRB) Q1 2025 Earnings Call TranscriptCellectar Biosciences Inc. (NASDAQ:CLRB ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Jim Caruso - President and CEO Chad Kolean - CFO Jarrod Longcor - COO Anne Marie...

2 months ago · seekingalpha.com
Cellectar Biosciences Inc. (CLRB) Q4 2024 Earnings Call TranscriptCellectar Biosciences Inc. (NASDAQ:CLRB ) Q4 2024 Earnings Conference Call March 13, 2025 8:30 AM ET Company Participants Anne Marie Fields – Managing Director-Precision AQ Jim Caruso – President and ...